Adam Gazzaley
David Dolby Distinguished Professor of Neurology, Physiology and Psychiatry at the University of California, San Francisco; Founder and Executive Director of Neuroscape
Data updated
Research Footprint
Adam Gazzaley appears in 8 tracked papers (2021–2026), most studied alongside Ketamine, DMT and Psilocybin, across Neuroimaging & Brain Measures, Anxiety Disorders and Depressive Disorders.
Most-cited paper: Canalization and plasticity in psychopathology (101 citations).
Frequent co-authors: Robin Carhart-Harris, Hannes Kettner and Fernando Rosas.
Background & Research
Adam Gazzaley is a neuroscientist and physician-scientist at UCSF with an M.D. and Ph.D. in neuroscience from Mount Sinai School of Medicine. He is the founder and executive director of Neuroscape, a translational neuroscience center focused on developing and validating technologies to assess and optimize brain function. His research spans attention, memory, aging, digital therapeutics, and neuroscience applications relevant to mental health and psychedelic science.
Key Impact
He is a prominent UCSF neuroscientist whose work on cognition, brain stimulation, digital therapeutics, and psychedelic-related brain dynamics intersects directly with emerging psychiatric and psychedelic medicine research.
Collaboration Network
22 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Adam Gazzaley is associated with.